before number of years, the UK has witnessed a revolution in health-related bodyweight‑reduction therapies — with the introduction of semaglutide (Wegovy®) for the growing reputation of tirzepatide (Mounjaro®). Now, A different name is drawing interest in both clinical and public health circles: